MLKL and hepatocellular carcinoma: Xiang et al. conducted another analysis in 30 human HCC specimens, this time investigating the way Cx32 expression affects necroptotic signaling network and necroptosis biomarkers (RIPK1, phosphorylated RIPK1–p-RIPK1, and phosphorylated MLKL–p-MLKL) expression levels [72].